EKRE, HANS-PETER,ERIKSSON, PER-OLOV,LINDAHL, ULF,HOLMER, ERIK
申请号：
CA2856492
公开号：
CA2856492C
申请日:
2012.12.19
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to a chemically modified glycosaminoglycanwith an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw, weight average)fromabout 4.6 to6.9 kDa. Also disclosed is a method of preparing the modified glycosaminoglycanand its medical uses.
